Astellas Pharma Inc. Short Interest Down 75.4 percent in September - MarketBeat
| YPH Stock | EUR 9.61 0.11 1.16% |
Roughly 51% of Astellas Pharma's investor base is interested to short. The analysis of current outlook of investing in Astellas Pharma suggests that many traders are impartial regarding Astellas Pharma's prospects. The current market sentiment, together with Astellas Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Astellas Pharma stock news signals to limit their universe of possible portfolio assets.
Astellas Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Astellas daily returns and investor perception about the current price of Astellas Pharma as well as its diversification or hedging effects on your existing portfolios.
Astellas |
Astellas Pharma Inc. Short Interest Down 75.4 percent in September MarketBeat
Read at news.google.com
 |
Astellas Pharma Fundamental Analysis
We analyze Astellas Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Astellas Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Astellas Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Astellas Pharma is rated below average in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Astellas Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Astellas Pharma stock to make a market-neutral strategy. Peer analysis of Astellas Pharma could also be used in its relative valuation, which is a method of valuing Astellas Pharma by comparing valuation metrics with similar companies.
Peers
Astellas Pharma Related Equities
| AMG | Amgen | 3.46 | ||||
| YPH | Astellas Pharma | 1.16 | ||||
| 6MK | Merck | 1.15 | ||||
| YPHA | ASTELLAS PHARMA | 1.07 | ||||
| BAYN | Bayer AG | 0.97 | ||||
| IDP | Biogen | 0.36 | ||||
| RHO6 | Roche Holding | 0.51 | ||||
| CVGU | CSPC PHARMACEUTGR | 1.74 | ||||
| BAYA | Bayer Aktiengesellscha | 2.83 |
Complementary Tools for Astellas Stock analysis
When running Astellas Pharma's price analysis, check to measure Astellas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astellas Pharma is operating at the current time. Most of Astellas Pharma's value examination focuses on studying past and present price action to predict the probability of Astellas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astellas Pharma's price. Additionally, you may evaluate how the addition of Astellas Pharma to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |